Cancer therapy costs influence treatment: a national survey of oncologists.

Published

Journal Article

A national survey of medical oncologists indicates that rising cancer treatment costs are influencing clinical practice, even as oncologists tend not to communicate with patients about costs. The survey shows that 84 percent of oncologists say that patients' out-of-pocket spending influences treatment recommendations. Only 43 percent always or frequently discuss costs with patients. Among those surveyed, 79 percent favor more comparative effectiveness research; 80 percent support more cost-effectiveness data, although only 42 percent feel well prepared to interpret it. The results suggest that physicians support federally funded comparative effectiveness research but that they wish to retain a central role in making decisions about how and when to use expensive cancer treatments. The results also support educating physicians about cost-effectiveness and how to communicate with patients regarding cost.

Full Text

Duke Authors

Cited Authors

  • Neumann, PJ; Palmer, JA; Nadler, E; Fang, C; Ubel, P

Published Date

  • January 2010

Published In

Volume / Issue

  • 29 / 1

Start / End Page

  • 196 - 202

PubMed ID

  • 20048377

Pubmed Central ID

  • 20048377

Electronic International Standard Serial Number (EISSN)

  • 1544-5208

International Standard Serial Number (ISSN)

  • 0278-2715

Digital Object Identifier (DOI)

  • 10.1377/hlthaff.2009.0077

Language

  • eng